There are two mouse P-glycoproteins that convey multidrug resistance, mdr1
(mdr1b and mdr3 (mdr1a), by serving as drug efflux transporters. These prot
eins each exhibit tissue specific expression. There is relatively high expr
ession of the mdr1 gene in the adrenals, the site of glucocorticoid and min
eralocorticoid hormone synthesis. We previously demonstrated that mdr1 gene
expression in murine thymoma cells correlated well with a decrease in thei
r ability to accumulate the glucocorticoid dexamethasone and their increase
d resistance to glucocorticoid-induced apoptosis. Additional evidence is pr
esented that supports the proposition that the mdr1 P-glycoprotein can tran
sport glucocorticoids. Specifically, introduction and expression of the mou
se mdr1 gene in the human HEK 293T cell line conveys a multidrug resistance
phenotype that. includes a reduced capacity to accumulate dexamethasone. M
oreover, isolation of additional mdr1-expressing mouse lymphoid cells, with
out using steroids in the selection, confirms the linkage between multidrug
resistance conveyed by the mdr1 P-glycoprotein and resistance to dexametha
sone. In contrast, two newly isolated lymphoid lines, selectively expressin
g the mdr3 gene, were not found to have increased dexamethasone resistance
or the capacity to accumulate significantly lower levels of hormone. The re
sults support the concept that the mdr1 and mdr3 P-glycoproteins may serve
alternative roles in the transport of endogenous substances such as steroid
s. (C) 1999 Elsevier Science Inc.